Company: SMNR
Filing Date: 2025-12-03
Form Type: 8-K
Source: 0001193125-25-306757
Chunk: 1

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-12-03
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

  Exhibit      Description                                                                   
                                                                                             
   Number                                                                                    
 ─────────────────────────────────────────────────────────────────────────────────────────────
      4.1      Description of Securities                                                     
      104      Cover Page Interactive Data File (embedded within the Inline XBRL document).  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  SEMNUR PHARMACEUTICALS, INC.                                             
  By:                               /s/ Jaisim Shah                        
  Name:                             Jaisim Shah                            
  Title:                            Chief Executive Officer and President  

Date: December 3, 2025